Comment on: Prior COVID-19 infection associated with increased risk of newly diagnosed erectile dysfunction

Sirpi Nackeeran,Ranjith Ramasamy
DOI: https://doi.org/10.1038/s41443-024-00912-8
2024-05-26
International Journal of Impotence Research
Abstract:Since the initial waves of the COVID-19 pandemic, there has been a growing body of literature illustrating the short and long-term health consequences of COVID-19 infection. The long-term symptoms have a significant impact on overall health, psychological distress, and quality of life. The most common long-term sequelae of COVID consist of well-known symptoms such as fatigue, difficulty concentrating, and shortness of breath [1, 2]. However, new diagnoses specific to organ systems not typically thought to be involved with acute COVID-19 infection have also been identified, such as pulmonary embolism and diabetes mellitus [1, 3]. Male reproductive organs are also theorized to be involved in COVID-19 infection [4]. Erectile dysfunction in particular has been investigated as a sequela of COVID-19 due to a shared pathway of endothelial dysfunction [5]. In the current issue of International Journal of Impotence Research , Hebert et al. evaluated whether recovery from a previous COVID-19 infection is associated with a new diagnosis of erectile dysfunction [6]. Two prior studies had established a similar association [7, 8], however the present study maintains a significant advantage with its ability to capture longitudinal patient visits regardless of visit setting or location by using IBM Market Scan. IBM Market Scan is a private database that collects data from all types of patient visits using insurance claims. They were able to use ICD-9 and ICD-10 codes to collect other clinical variables and track outcomes. The authors could control for several comorbidities associated with erectile dysfunction within a Cox proportional hazards model, and they found a 27% increased chance of new erectile dysfunction following COVID-19 infection. This is similar to the findings from the study by Chu et al. that showed a 20% increased risk of developing new onset erectile dysfunction after COVID-19 infection [7].
urology & nephrology
What problem does this paper attempt to address?